The role of continuing care in 9-year cost trajectories of patients with intakes into an outpatient alcohol and drug treatment program.

Medical Care
Sujaya ParthasarathyConstance Weisner

Abstract

The importance of a continuing care approach for substance use disorders (SUDs) is increasingly being recognized. Our prior research found that a Continuing Care model for SUDs that incorporates 3 components (regular primary care, and specialty SUD and psychiatric treatment as needed) is beneficial to long-term remission. The study builds on this work to examine the cost implications of this model. To examine associations between receiving Continuing Care and subsequent health care costs over 9 years among adults entering outpatient SUD treatment in a private nonprofit, integrated managed care health plan. We also compare the results to a similar analysis of a demographically matched control group without SUDs. Longitudinal observational study. Measures collected over 9 years include demographic characteristics, self-reported alcohol and drug use and Addiction Severity Index, and health care utilization and cost data from health plan databases. Within the treatment sample, SUD patients receiving all components of Continuing Care had lower costs than those receiving fewer components. Compared with the demographically matched non-SUD controls, those not receiving Continuing Care had significantly higher inpatient costs (excess co...Continue Reading

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Sep 1, 1992·Medical Care·A C GoodmanJ R Hankin
Mar 1, 1991·Alcoholism, Clinical and Experimental Research·H D Holder, J O Blose
Jan 1, 1986·Advances in Alcohol & Substance Abuse·H D Holder, J B Hallan
Nov 1, 1996·Alcoholism, Clinical and Experimental Research·S P ChouD A Dawson
Feb 12, 1998·Annals of Internal Medicine·J V Selby
Dec 31, 1997·Annals of Internal Medicine·M Von KorffE H Wagner
Jul 1, 1993·Journal of Mental Health Administration·R D LennoxE M Bohlig
Jul 1, 1999·The Psychiatric Clinics of North America·M D Stein
Oct 3, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·R A Hoff, R A Rosenheck
Oct 4, 2000·JAMA : the Journal of the American Medical Association·A T McLellanH D Kleber
Oct 12, 2001·JAMA : the Journal of the American Medical Association·C WeisnerY Lu
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Mar 6, 2003·Medical Care·Sujaya ParthasarathyConstance Weisner
Nov 12, 2003·Archives of Internal Medicine·Jennifer R MertensConstance M Weisner
Sep 17, 2004·Addiction·Kerrianne WattRoderick J McClure
Feb 9, 2005·Archives of General Psychiatry·James R McKayHelen M Pettinati
May 27, 2005·Drug and Alcohol Dependence·Sujaya Parthasarathy, Constance M Weisner
Dec 13, 2005·Alcoholism, Clinical and Experimental Research·Lee Ann KaskutasConstance Weisner
Apr 26, 2006·Alcoholism, Clinical and Experimental Research·Felicia W ChiConstance Weisner
Mar 17, 2007·Drug and Alcohol Review·Cheryl J Cherpitel
Feb 23, 2008·Addiction Science & Clinical Practice·Michael Dennis, Christy K Scott
Jun 23, 2009·Journal of Substance Abuse Treatment·M Tyler Boden, Rudolf Moos
Oct 5, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·Felicia W ChiConstance M Weisner

❮ Previous
Next ❯

Citations

Jan 28, 2014·Journal of Substance Abuse Treatment·Felicia W ChiJennifer Mertens
May 25, 2013·Journal of Substance Abuse Treatment·Elizabeth EvansYih-Ing Hser
May 30, 2012·The Psychiatric Clinics of North America·David R PatingDouglas M Ziedonis
May 1, 2012·Drug and Alcohol Dependence·Jennifer R MertensConstance M Weisner
Feb 20, 2019·Alcoholism, Clinical and Experimental Research·Mary E McCaulRajita Sinha
Feb 16, 2020·Aging Clinical and Experimental Research·Cathleen S Colón-EmericOrla C Sheehan
Jun 22, 2017·The American Journal of Drug and Alcohol Abuse·Andrea H Kline-SimonConstance Weisner
Jul 21, 2017·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Amber L BahorikCynthia I Campbell
Apr 10, 2013·Addiction·Connie Weisner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.